Selected article for: "asymptomatic infection and clinical report"
Author: Murchison, Ann P.; Sweid, Ahmad; Dharia, Robin; Theofanis, Thana N.; Tjoumakaris, Stavropoula I.; Jabbour, Pascal M.; Bilyk, Jurij R.
Title: Monocular visual loss as the presenting symptom of COVID-19 infection
  • Cord-id: rrcbps2h
  • Document date: 2020_12_15
    • ID: rrcbps2h
    Snippet: Background and Importance: Additional time is needed to determine the exact impact of COVID-19 on acute cerebrovascular disease incidence, but recently published data has correlated COVID-19 to large vessel occlusion strokes. Clinical Presentation: We report the first case of central retinal artery occlusion (CRAO) as the initial manifestation of COVID-19 infection. Subsequent neuroimaging revealed a large thrombus extending into the internal carotid artery. Conclusion: This case illustrates the
    Document: Background and Importance: Additional time is needed to determine the exact impact of COVID-19 on acute cerebrovascular disease incidence, but recently published data has correlated COVID-19 to large vessel occlusion strokes. Clinical Presentation: We report the first case of central retinal artery occlusion (CRAO) as the initial manifestation of COVID-19 infection. Subsequent neuroimaging revealed a large thrombus extending into the internal carotid artery. Conclusion: This case illustrates the need to suspect COVID-19 infection in patients presenting with retinal arterial occlusion, including individuals who are asymptomatic or minimally symptomatic for COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • abnormal study and low density lipoprotein: 1
    • acute ischemic stroke and additional time: 1, 2, 3, 4, 5
    • acute ischemic stroke and lmwh weight heparin: 1, 2
    • acute ischemic stroke and low density: 1, 2, 3, 4, 5
    • acute ischemic stroke and low density lipoprotein: 1, 2, 3, 4
    • acute ischemic stroke and low molecular lmwh weight heparin: 1, 2
    • acute ischemic stroke and low molecular weight heparin: 1, 2
    • acute macular neuroretinopathy and macular neuroretinopathy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute onset and additional time: 1
    • acute onset and lmwh weight heparin: 1, 2
    • acute onset and low density: 1
    • acute onset and low density lipoprotein: 1
    • acute onset and low molecular lmwh weight heparin: 1, 2
    • acute onset and low molecular weight heparin: 1, 2, 3, 4
    • acute onset and macular neuroretinopathy: 1
    • additional time and low density: 1, 2
    • additional time and low density lipoprotein: 1
    • lmwh weight heparin and low density: 1
    • lmwh weight heparin and low molecular lmwh weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25